Describes 15 new patients (including 1 fetus) with 6q16 deletions, which is the most common variant in patients exhibiting the PWS-like phenotype
Investigated using chromosomal microarray analysis
All reported 6q16 deletions occurred de novo in symptomatic patients
Other genes also included in these deletions (listed in supplemental information)
PMID: 26795956
Performed copy number variation analysis of the 6q14.1–6q16.3 region followed by mutation analysis of SIM1 and MRAP2 in a PWL cohort.
p.P352S was identified in a ten-year-old boy presenting with early-onset extreme obesity, intellectual disability and behavior and learning deficits. In addition, the patient shows small hands and feet and an acceleration in bone age. He was clinically diagnosed with PWS although this could not be confirmed molecularly as no aberration on chromosome 15q11.2–q13 was detected with MS-MLPA.
De novo interstitial deletion at 6q16.1–q21 (chr6:98,119,288–107,977,239 (hg18)), that included SIM1 and 30 other genes, was identified in a 12 year old male with Prader–Willi-like syndrome
PMID: 18648397
Report 5 patients with overlapping interstitial 6q16 deletions and Prader–Willi-like phenotype
Cases 2 and 3 show heart defects (ductus arteriosus and atrial septal defects in case 2, tetralogy of Fallot in case 3) and are haploinsufficient for the POPDC3 gene
PMID: 12161602
Identified a 6q16.1-q21 deletion in a patient with a Prader-Willi-like phenotype
c.383T>C, c.454C>G, and c.2119G>C were also seen in controls
Generated stable cell lines expressing the mutant SIM1 proteins and tested their ability to activate the transcription of a SIM1-responsive reporter gene. Of the 13 variants examined, 9 (S71R, R171H, Q152E, I128T, L238R, P497R, R550H, D707H, and T712I) had significantly reduced activity in this assay when paired with the proposed in vivo partner, ARNT2
PMID: 16829351
Screening for the SIM1 gene deletion performed on 87 patients with PWS-like phenotype, also describe the fifth case of syndromic obesity with an interstitial deletion of the chromosome segment 6q16-q21
Other papers on SIM1 and obesity: PMID: 31872862, PMID: 10587584, PMID: 25234154 (obesity and developmental delay), PMID: 33434169 (obesity and hypopituitarism)
Segregation Evidence:
Case/Control Evidence:
Experimental Evidence:
Source:
Clinical ValidityPoints Total
Source:
Clinical ValidityClassification
Definitive (12pts)
Strong (12pts)
Moderate (7-11pts)
Limited (0.1-6pts)
No genetic evidence
Refuted
Disputed
Source:
MolecularMechanism
Loss of function
Gain of function
Dominant negative
Unknown
Other
No evidence for haploinsufficiency in ClinGen (2012), but there are pLOF variants reported in ClinVar for SIM1-related disorder
The literature notes that SIM1 loss of function seems to be associated with obesity and may also be associated with PWL-related clinical features (however there is incomplete penetrance)